← FDA Drug Approvals (Drugs@FDA)

BLOXIVERZ

NDA · New Drug Application · Sponsor: EXELA PHARMA · Approved 2013-05-31

Drug application

FDA Application #

NDA204078

Application type

New Drug Application

Brand name

BLOXIVERZ

Generic name

NEOSTIGMINE METHYLSULFATE

Active ingredients

NEOSTIGMINE METHYLSULFATE

Dosage form

SOLUTION

Route

INTRAVENOUS

Marketing status

Prescription

Sponsor

EXELA PHARMA

Manufacturer

Exela Pharma Sciences, LLC

First approval

2013-05-31

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown